FI108296B - Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI108296B
FI108296B FI946140A FI946140A FI108296B FI 108296 B FI108296 B FI 108296B FI 946140 A FI946140 A FI 946140A FI 946140 A FI946140 A FI 946140A FI 108296 B FI108296 B FI 108296B
Authority
FI
Finland
Prior art keywords
formula
diazabicyclo
compounds
compound
substance
Prior art date
Application number
FI946140A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI946140A (fi
FI946140A0 (fi
Inventor
Jr Harry R Howard
Kevin D Shenk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI946140A0 publication Critical patent/FI946140A0/fi
Publication of FI946140A publication Critical patent/FI946140A/fi
Application granted granted Critical
Publication of FI108296B publication Critical patent/FI108296B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
FI946140A 1993-12-29 1994-12-28 Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi FI108296B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17503493A 1993-12-29 1993-12-29
US17503493 1993-12-29

Publications (3)

Publication Number Publication Date
FI946140A0 FI946140A0 (fi) 1994-12-28
FI946140A FI946140A (fi) 1995-06-30
FI108296B true FI108296B (fi) 2001-12-31

Family

ID=22638565

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946140A FI108296B (fi) 1993-12-29 1994-12-28 Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi

Country Status (26)

Country Link
US (2) US5854239A (ru)
EP (1) EP0737194B1 (ru)
JP (1) JP2895630B2 (ru)
KR (1) KR100197454B1 (ru)
CN (1) CN1046515C (ru)
AT (1) ATE177099T1 (ru)
AU (1) AU699465B2 (ru)
BR (1) BR9408450A (ru)
CA (1) CA2180263C (ru)
CO (1) CO4230019A1 (ru)
CZ (1) CZ282567B6 (ru)
DE (1) DE69416869T2 (ru)
DK (1) DK0737194T3 (ru)
ES (1) ES2127946T3 (ru)
FI (1) FI108296B (ru)
GR (1) GR3029853T3 (ru)
HU (1) HUT74682A (ru)
IL (1) IL112118A (ru)
NO (1) NO305600B1 (ru)
NZ (1) NZ274915A (ru)
PE (1) PE49395A1 (ru)
PL (1) PL179435B1 (ru)
RU (1) RU2124014C1 (ru)
TW (1) TW369526B (ru)
WO (1) WO1995018129A1 (ru)
ZA (1) ZA9410339B (ru)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737194B1 (en) * 1993-12-29 1999-03-03 Pfizer Inc. Diazabicyclic neurokinin antagonists
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
ATE367811T1 (de) * 2000-06-12 2007-08-15 Univ Rochester Methode zur behandlung von hitzewallungen, durch verwendung eines tachikinin-rezeptor antagonisten
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7439253B2 (en) 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ATE550019T1 (de) 2005-05-17 2012-04-15 Merck Sharp & Dohme Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
US20060281670A1 (en) * 2005-06-10 2006-12-14 Wisconsin Alumni Research Foundation (Warf) Compositions and methods for modulating angiogenesis
US7956050B2 (en) 2005-07-15 2011-06-07 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP1940842B1 (en) 2005-09-29 2012-05-30 Merck Sharp & Dohme Corp. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
EP2698157B1 (en) 2006-09-22 2015-05-20 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
TWI454262B (zh) * 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
EP2109608B1 (en) 2007-01-10 2011-03-23 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
AU2008233662B2 (en) 2007-04-02 2012-08-23 Msd K.K. Indoledione derivative
US8389553B2 (en) 2007-06-27 2013-03-05 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
RU2445314C9 (ru) 2008-01-18 2013-04-10 Мерк Шарп Энд Домэ Корп. Ингибиторы бета-лактамаз
CN102014631A (zh) 2008-03-03 2011-04-13 泰格尔医药科技公司 酪氨酸激酶抑制剂
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
EP2413932A4 (en) 2009-04-01 2012-09-19 Merck Sharp & Dohme INHIBITORS OF AKT ACTIVITY
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
CA2760837C (en) 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
EP2488028B1 (en) 2009-10-14 2020-08-19 Merck Sharp & Dohme Corp. Substituted piperidines that increase p53 activity and the uses thereof
WO2011163330A1 (en) 2010-06-24 2011-12-29 Merck Sharp & Dohme Corp. Novel heterocyclic compounds as erk inhibitors
CN103068980B (zh) 2010-08-02 2017-04-05 瑟纳治疗公司 使用短干扰核酸（siNA）的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1（CTNNB1）基因表达的抑制
KR102072631B1 (ko) 2010-08-17 2020-02-03 시르나 쎄러퓨틱스 인코퍼레이티드 짧은 간섭 핵산 （ｓｉＮＡ）을 사용한 Ｂ형 간염 바이러스 （ＨＢＶ） 유전자 발현의 ＲＮＡ 간섭 매개 억제
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
EP3766975A1 (en) 2010-10-29 2021-01-20 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
CA2822758C (en) * 2010-12-22 2018-03-20 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
US20140046059A1 (en) 2011-04-21 2014-02-13 Piramal Enterprises Limited Process for the preparation of morpholino sulfonyl indole derivatives
DK2748165T3 (en) * 2011-08-27 2016-12-19 Wockhardt Ltd 1,6-diazabicyclo [3,2,1] octane-7-ON DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
CN103649088B (zh) * 2011-08-30 2016-05-11 沃克哈特有限公司 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
WO2013038330A1 (en) * 2011-09-13 2013-03-21 Wockhardt Limited Nitrogen containing compounds and their use
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
AR090539A1 (es) * 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
US20150299696A1 (en) 2012-05-02 2015-10-22 Sirna Therapeutics, Inc. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
AU2013268415B2 (en) * 2012-05-30 2017-05-25 Meiji Seika Pharma Co., Ltd. Novel beta-lactamase inhibitor and method for producing same
WO2014052563A2 (en) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
ES2651347T3 (es) 2012-11-28 2018-01-25 Merck Sharp & Dohme Corp. Composiciones y métodos para el tratamiento del cáncer
CA2895504A1 (en) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
CN105143225A (zh) * 2013-03-08 2015-12-09 沃克哈特有限公司 一种制备(2s,5r)-7-氧代-6-磺酰氧基-2-[((3r)-哌啶-3-羰基)-肼基羰基]-1,6-二氮杂-双环[3.2.1]辛烷的方法
MX2015011721A (es) * 2013-03-08 2015-12-01 Wockhardt Ltd Proceso para la preparacion de (2s,5r) -7-oxo-6-sulfooxi-2-[((3r)- pirrolidin-3-carbonil) carbonil hidrazino]-1,6-diaza-biciclo[3.2.1 ] octano.
NZ711343A (en) * 2013-03-08 2016-07-29 Wockhardt Ltd Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
NZ711329A (en) * 2013-03-08 2016-06-24 Wockhardt Ltd A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
CN105555787B (zh) * 2013-09-24 2017-08-08 明治制果药业株式会社 二氮杂二环辛烷衍生物的制备方法及其中间体
MX2017006383A (es) 2014-11-17 2017-08-21 Entasis Therapeutics Ltd Terapia de combinacion para el tratamiento de infecciones bacterianas resistentes.
JP2018510198A (ja) 2015-04-03 2018-04-12 ミュタビリスＭｕｔａｂｉｌｉｓ 複素環式化合物及びそれらの細菌感染症の予防または治療のための使用
LT3512851T (lt) 2016-09-16 2022-10-25 Entasis Therapeutics Limited Beta-laktamazės inhibitorių junginiai
DK3630111T3 (en) 2017-05-08 2022-03-14 Entasis Therapeutics Inc Compounds and methods for treating bacterial infections
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
CN108610313B (zh) * 2018-06-08 2022-03-04 三峡大学 一种酶抑制剂及其应用
WO2020033284A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
WO2020033282A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3494923A (en) * 1965-05-28 1970-02-10 Sterling Drug Inc 1,2,3,4,5,8-hexahydro-1,5-methanobenzo (f)(1,4)diazocine
ATE115581T1 (de) * 1991-03-01 1994-12-15 Pfizer 1-azabicyclo(3.2.2>nonan-3-aminderivate.
EP0737194B1 (en) * 1993-12-29 1999-03-03 Pfizer Inc. Diazabicyclic neurokinin antagonists

Also Published As

Publication number Publication date
IL112118A0 (en) 1995-03-15
NO305600B1 (no) 1999-06-28
FI946140A (fi) 1995-06-30
DE69416869D1 (de) 1999-04-08
BR9408450A (pt) 1997-08-05
FI946140A0 (fi) 1994-12-28
US5854239A (en) 1998-12-29
HU9601790D0 (en) 1996-09-30
KR100197454B1 (ko) 1999-06-15
PE49395A1 (es) 1996-01-06
CN1046515C (zh) 1999-11-17
JP2895630B2 (ja) 1999-05-24
CA2180263C (en) 2000-05-16
NO962742D0 (no) 1996-06-28
TW369526B (en) 1999-09-11
CZ282567B6 (cs) 1997-08-13
EP0737194B1 (en) 1999-03-03
CN1139434A (zh) 1997-01-01
PL179435B1 (pl) 2000-09-29
DE69416869T2 (de) 1999-07-01
WO1995018129A1 (en) 1995-07-06
CO4230019A1 (es) 1995-10-19
NZ274915A (en) 1997-11-24
JPH09500904A (ja) 1997-01-28
AU8002194A (en) 1995-07-17
NO962742L (no) 1996-06-28
PL315193A1 (en) 1996-10-14
GR3029853T3 (en) 1999-07-30
HUT74682A (en) 1997-01-28
DK0737194T3 (da) 1999-09-27
US6110919A (en) 2000-08-29
AU699465B2 (en) 1998-12-03
ES2127946T3 (es) 1999-05-01
ZA9410339B (en) 1996-06-28
CZ188696A3 (en) 1996-10-16
EP0737194A1 (en) 1996-10-16
IL112118A (en) 1998-10-30
ATE177099T1 (de) 1999-03-15
RU2124014C1 (ru) 1998-12-27

Similar Documents

Publication Publication Date Title
FI108296B (fi) Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi
FI113654B (fi) Menetelmä terapeuttisesti käyttökelpoisten atsabisyklo[2.2.2]oktaani-3-amiinien valmistamiseksi
EP0675886B1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
FI108794B (fi) Menetelmä terapeuttisesti käyttökelpoisten fluorialkoksiaryylisubstituoitujen metyyliaminokinuklidiiniyhdisteiden valmistamiseksi
US5688806A (en) Spiroazacyclic derivatives as substance P antagonists
US5741797A (en) Heteroatom substituted alkyl benzylaminoquinuclidines
US5929094A (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
PT862567E (pt) 5-azabiciclo(3.1.0)hexilalquil-2-piperidonas e -glutarimidas como antagonistas do receptor de neurocinina
SK15612002A3 (sk) Azabicyklické karbamáty, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú ako účinné látky
JP2018526399A (ja) ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール
EP0573522A1 (en) 1-Azabicyclo [3.2.2.] Nonan-3-amine derivatives.
IE65000B1 (en) Quinuclidine derivatives
EP0708771A1 (en) Benzyloxyquinuclidines as substance p antagonists
CZ20012151A3 (cs) Chinolinové deriváty
AU2481292A (en) Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
IE921987A1 (en) Azanorbornane derivatives
HUT76928A (hu) Amino-metil-fenil-imidazol-származékok alkalmazása emlékezetjavító gyógyászati készítmények előállítására
JP2004526788A (ja) 疾患治療用の置換型アザ二環式基（ニコチン性アセチルコリン受容体アンタゴニスト）
US20030232853A1 (en) Azabicyclic compounds for the treatment of disease
US6849620B2 (en) N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
JP2008517010A (ja) ハロゲン置換ベンゾジアゼピン誘導体
WO1998017276A1 (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
JPS6396187A (ja) インドローピラジノーベンゾジアゼピン誘導体
BG106162A (bg) Трициклени аналгетици
JPH08509501A (ja) Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類

Legal Events

Date Code Title Description
MA Patent expired